A crucial element of regenerative medicine and drug discovery lies in the ability to multiply human stem cell groups to sufficient numbers for therapeutic applications. Traditionally, limited cell availability posed a significant hindrance to advancement in these fields. Consequently, considerable effort has been directed towards optimizing protoco